HNRNPA1P10: A Potential Drug Target and Biomarker for Various Diseases

Target Name: HNRNPA1P10

NCBI ID: G664709

HNRNPA1P10

Other Name(s): Heterogeneous nuclear ribonucleoprotein A1 pseudogene 10 | HNRPA1L-2 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 10

HNRNPA1P10: A Potential Drug Target and Biomarker for Various Diseases

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 10 (HNRNPA1P10) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. HNRNPA1P10 is a key regulator of gene expression in the cell and has been shown to play a role in the development and progression of these diseases.

HNRNPA1P10 is a member of the heterogeneous nuclear ribonucleoprotein (hnRNA) family, which are a group of non-coding RNAs that play a central role in the regulation of gene expression in the cell. HnRNPA1P10 is characterized by its ability to interact with the protein Prm1, which is a key regulator of hnRNA stability and translation efficiency. This interaction between HNRNPA1P10 and Prm1 has been shown to play a role in the regulation of gene expression and the development of various diseases.

One of the key functions of HNRNPA1P10 is its ability to regulate the translation of pre-mRNA into protein. HNRNPA1P10 has been shown to interact with the protein GFP, which is a common target of post-translational modification (PTM). This interaction between HNRNPA1P10 and GFP has been shown to play a role in the regulation of gene expression and the development of various diseases.

In addition to its role in gene expression, HNRNPA1P10 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and autophagy. HNRNPA1P10 has been shown to interact with the proteinBeclin-1, which is a key regulator of cell growth and apoptosis. This interaction between HNRNPA1P10 and Beclin-1 has been shown to play a role in the regulation of cellular processes and the development of various diseases.

HNRNPA1P10 has also been shown to play a role in the regulation of inflammation and immune responses. HNRNPA1P10 has been shown to interact with the proteinNF-kappa-B, which is a key regulator of inflammation and immune responses. This interaction between HNRNPA1P10 and NF-kappa-B has been shown to play a role in the regulation of inflammation and immune responses and the development of various diseases.

Despite its potential as a drug target and biomarker, HNRNPA1P10 has not yet been fully characterized and its functions are not yet fully understood. Further research is needed to fully determine the role of HNRNPA1P10 in the regulation of gene expression and the development of various diseases.

In conclusion, Heterogeneous nuclear ribonucleoprotein A1 pseudogene 10 (HNRNPA1P10) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. HNRNPA1P10 is a key regulator of gene expression in the cell and has been shown to play a role in the development and progression of these diseases. Further research is needed to fully determine the functions of HNRNPA1P10 and its potential as a drug target and biomarker.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein A1 Pseudogene 10

The "HNRNPA1P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPA1P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets